Ishikawa, K.; Nakamura, T.; Kawai, F.; Ota, E.; Mori, N.
Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients. Cancers 2024, 16, 1934.
https://doi.org/10.3390/cancers16101934
AMA Style
Ishikawa K, Nakamura T, Kawai F, Ota E, Mori N.
Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients. Cancers. 2024; 16(10):1934.
https://doi.org/10.3390/cancers16101934
Chicago/Turabian Style
Ishikawa, Kazuhiro, Tomoaki Nakamura, Fujimi Kawai, Erika Ota, and Nobuyoshi Mori.
2024. "Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients" Cancers 16, no. 10: 1934.
https://doi.org/10.3390/cancers16101934
APA Style
Ishikawa, K., Nakamura, T., Kawai, F., Ota, E., & Mori, N.
(2024). Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients. Cancers, 16(10), 1934.
https://doi.org/10.3390/cancers16101934